Zinc for GNAO1 Encephalopathy: Preclinical Profiling and a Clinical Case

GNAO1 (G protein alpha subunit O1) gene mutations are considered one of the primary causes of severe pediatric encephalopathy. This encephalopathy typically manifests as epilepsy, movement disorders, developmental delay, and intellectual disability, with limited effectiveness of current treatments. The GαO protein encoded by the GNAO1 gene is a key...